Therapeutic potential of cannabidiol supplementation in mitigating lipid precursors of inflammation in hepatic steatosis progression
Our observations confirmed that CBD, which affects early indicators of inflammation, has the potential to become a new and safe, promising supportive drug for hepatic inflammation and steatosis treatment.
Authors
- Karolina Konstantynowicz-Nowicka (ORCID: https://orcid.org/0000-0001-9274-5488)
- Magdalena A. Zabielska-Kaczorowska (ORCID: https://orcid.org/0000-0001-8661-8415)
- Adrian Chabowski (ORCID: https://orcid.org/0000-0002-7407-8156)
- Klaudia Sztolsztener (ORCID: https://orcid.org/0000-0003-1354-7585)
- Piotr Franciszek Kurzyna (ORCID: https://orcid.org/0000-0002-7738-4538)
- Ewa Harasim-Symbor
- Mateusz Zwierz
Institutions
- Medical University of Białystok (PL)
- Gdańsk Medical University (PL)
Publication Details
- Journal
- Journal of Cannabis Research
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1186/s42238-026-00413-z
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00